Summary

Europe Ambulatory Cardiac Monitoring Devices Market is valued approximately at USD 1.24 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 9.89% over the forecast period 2024-2032. Ambulatory cardiac monitoring devices are handheld instruments that are intended to continually record the electrical activity of the heart as the patient goes about his regular activities. These devices are vital for the diagnosis and treatment of heart disorders such as arrhythmias and unexplained fainting. They include Holter monitors, event monitors, implanted loop recorders (ILR), and mobile cardiac telemetry (MCT). They provide precise data for early identification and timely intervention by capturing sporadic occurrences that may be overlooked during brief clinical assessments. These gadgets greatly increase cardiac diagnosis and treatment accuracy by enabling longer monitoring times and more patient mobility. The focus on value-based healthcare is a key trend that is supporting the growth of the Europe ambulatory Cardiac Monitoring Devices Market at a substantial rate. The shift towards value-based healthcare models in Europe emphasizes patient outcomes, cost-effectiveness, and quality of care. Ambulatory cardiac monitoring devices play a vital role in value-based care by supporting proactive management of cardiac conditions, reducing hospitalizations, and improving patient outcomes.

Many European countries emphasize preventative healthcare. Ambulatory cardiac monitoring allows for early detection of heart issues, reducing the burden on healthcare systems. The rising incidences of cardiovascular diseases across Europe is a significant driver for the market growth. As per data released by the British Heart Foundation (BHF) in August 2022, approximately 7.6 million individuals in the United Kingdom are affected by heart and circulatory diseases. Conditions such as arrhythmias, heart failure, and atrial fibrillation necessitate continuous monitoring, leading to a higher demand for ambulatory cardiac monitoring devices. Moreover, Europe maintains stringent regulatory standards for medical devices, ensuring safety, efficacy, and data privacy. This supportive regulatory environment encourages the adoption of ambulatory cardiac monitoring devices by healthcare providers and patients. However, ambulatory cardiac monitoring is associated with a strict regulatory framework and high cost which is likely to stifle market growth during the forecast period of 2024-2032.

The key countries considered for the Europe Ambulatory Cardiac Monitoring Devices Market study includes UK, Germany, France, Italy, Spain, and Rest of Europe. In 2023, Germany was the dominating region in the Ambulatory Cardiac Monitoring Devices Market in terms of revenue. The increasing awareness about early detection and management of cardiac conditions is driving acceptance among patients and healthcare providers resulting to the market's growth in the region. Along with this, there is a high focus on remote patient monitoring (RPM) solutions, driven by telemedicine adoption and efforts to improve healthcare cost-efficiency and patient outcomes, which is leveraging opportunities for the market expansion. Whereas, the market in UK is expected to grow at the fastest rate over the forecast period.

Major market player included in this report are:
Koninklijke Philips N.V
Biotronik SE & Co. KG
GE Healthcare
Company 4
Company 5
Company 6
Company 7
Company 8
Company 9
Company 10

The detailed segments and sub-segment of the market are explained below:

By Type
ECG Devices
Holter Monitors
Event Monitors
Implantable Loop Recorders
Mobile Cardiac Telemetry

By End-use
Ambulatory Care Centers
Hospitals & Clinics
Others

By Region:
Europe
UK
Germany
France
Spain
Italy
ROE

Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032

Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and Country level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market

ページTOPに戻る

Table of Contents

Chapter 1. Europe Ambulatory Cardiac Monitoring Devices Market Definition and Research Assumptions
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer’s Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates

Chapter 2. Executive Summary
2.1. Europe Ambulatory Cardiac Monitoring Devices Market Size & Forecast (2022- 2032)
2.2. Regional Summary
2.3. Segmental Summary
2.3.1. By Type
2.3.2. By End-use
2.4. Key Trends
2.5. Recession Impact
2.6. Analyst Recommendation & Conclusion
Chapter 3. Europe Ambulatory Cardiac Monitoring Devices Market Dynamics
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
Chapter 4. Europe Ambulatory Cardiac Monitoring Devices Market: Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economic
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Europe Ambulatory Cardiac Monitoring Devices Market Size & Forecasts by Type 2022-2032
5.1. ECG Devices
5.2. Holter Monitors
5.3. Event Monitors
5.4. Implantable Loop Recorders
5.5. Mobile Cardiac Telemetry
Chapter 6. Europe Ambulatory Cardiac Monitoring Devices Market Size & Forecasts by End-use 2022-2032
6.1. Ambulatory Care Centers
6.2. Hospitals & Clinics
6.3. Others
Chapter 7. Europe Ambulatory Cardiac Monitoring Devices Market Size & Forecasts by Country 2022-2032
7.1. U.K. Ambulatory Cardiac Monitoring Devices Market
7.1.1. Type breakdown size & forecasts, 2022-2032
7.1.2. End-use breakdown size & forecasts, 2022-2032
7.2. Germany Ambulatory Cardiac Monitoring Devices Market
7.3. France Ambulatory Cardiac Monitoring Devices Market
7.4. Spain Ambulatory Cardiac Monitoring Devices Market
7.5. Italy Ambulatory Cardiac Monitoring Devices Market
7.6. Rest of Europe Ambulatory Cardiac Monitoring Devices Market
Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.1.1. Company 1
8.1.2. Company 2
8.1.3. Company 3
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Koninklijke Philips N.V
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Market Strategies
8.3.2. Biotronik SE & Co. KG
8.3.3. GE Healthcare
8.3.4. Company 4
8.3.5. Company 5
8.3.6. Company 6
8.3.7. Company 7
8.3.8. Company 8
8.3.9. Company 9
8.3.10. Company 10
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes